CAS 131926-98-2: 5-HYDROXY LANSOPRAZOLE

Description: 5-Hydroxy Lansoprazole is a derivative of Lansoprazole, which is a proton pump inhibitor (PPI) commonly used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. This compound is characterized by the presence of a hydroxyl group at the fifth position of the Lansoprazole structure, which may influence its pharmacological properties and metabolic stability. It typically appears as a white to off-white solid and is soluble in organic solvents. The molecular formula reflects its complex structure, which includes a benzimidazole ring, a pyridine ring, and a sulfinyl group. The compound's mechanism of action involves the inhibition of the H+/K+ ATPase enzyme in the gastric parietal cells, leading to decreased gastric acid secretion. As a metabolite of Lansoprazole, 5-Hydroxy Lansoprazole may play a role in the drug's overall efficacy and safety profile, although its specific pharmacokinetics and dynamics can vary. Understanding its characteristics is essential for evaluating its therapeutic potential and interactions within the body.

Formula: C₁₆H₁₄F₃N₃O₃S

Synonyms:

• 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-5-ol
• 5-Hydroxy Lansoprazole >90%

5-Hydroxylansoprazole

CAS: 131926-98-2

5-Hydroxylansoprazole (AG1908) is the active metabolite of plasma Lansoprazole, inhibits the proton pump, and is …

• Formula: C₁₆H₁₄F₃N₃O₃S
• Purity: 99.00%
• Color and Shape: Solid
• Molecular weight: 385.36

5-Hydroxy Lansoprazole

CAS: 131926-98-2

• Formula: C₁₆H₁₄F₃N₃O₃S
• Color and Shape: Pink Solid
• Molecular weight: 385.36

2-[[[3-Methyl-4-(2,2,2-Trifluoroethoxy)-2-Pyridinyl]Methyl]Sulfinyl]-1H-Benzimidazol-6-Ol

CAS: 131926-98-2

2-[[[3-Methyl-4-(2,2,2-Trifluoroethoxy)-2-Pyridinyl]Methyl]Sulfinyl]-1H-Benzimidazol-6-Ol is a metabolite of omeprazole. It has been found to be a major metabolite …

• Formula: C₁₆H₁₄F₃N₃O₃S
• Purity: Min. 95%
• Molecular weight: 385.36 g/mol